Becton Dickinson & Co. (BDX) Company Profile & Statistics

Becton Dickinson & Co.
BDX
(NYSE)
Closed
225.46
+3.07 (+1.38%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
222.02
High
225.73
Low
221.35

About Becton Dickinson & Co.

CEO

N/A

Headquarters

N/A

Auditor

N/A

Employees

N/A

Share Holders

N/A

Website

N/A

Industry

medical specialties

Sector

health technology

Company Overview

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.

Becton Dickinson & Co. Statistics

Valuation Measures

Market Capitalization ²	65.17B
Enterprise Value	83.42B
Enterprise Value/EBITDA (ttm)	24.01
Price to Earnings Ratio (ttm)	16.92
Price to Book (mrq)	2.48
Price to Sales (ttm)	3.19
Price to Cash (ytd)	10.53

Profitability

Gross Margin (ttm)	33.74%
Operating Margin (ttm)	18.95%
Profit Margin (ttm)	6.59%
Return on Equity (ttm)	14.89%
Return on Invested Capital (ttm)	3.11%
Return on Assets (ttm)	6.98%

Income Statement

Revenue (ttm)	20.18B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	9.15B
EBITDA (ttm)³	3.47B
Net Income Avi to Common (ttm)	1.73B
Diluted EPS (ttm)	5.94

Share Statistics

Beta (5Y Monthly)	0.43
52-Week Change	-1.94%
S&P500 52-Week Change	30.55%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	1.71%
Float ⁴	288.15M
% Held by Insiders	0.31%
% Held by Institutions	86.97%

Balance Sheet

Total Cash (mrq)	2.30B
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	20.11B
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	N/A
Quick Ratio (mrq)	0.74%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	N/A
Free Cash Flow (ytd)	0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Becton Dickinson & Co.

Trade With A Regulated Broker